Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys to Trim Workforce

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Accelrys plans to reduce its workforce by up to 15 employees as part of a streamlining of its business, it disclosed in a quarterly earnings document filed with the US Securities and Exchange Commission earlier this month.

The San Diego-based life sciences software solutions company said that it started the process on May 3 and expects to complete it by the end of the year. The total reduction in its workforce will be between 10 and 15 employees.

Accelrys said that it will take a charge of $1 million in connection with the action.

In its SEC document, the firm said that the reduction is "in connection with the streamlining of its operation and integrating its content business."

Max Carnecchia, president and CEO of Accelrys, hinted at the action when the firm released its first-quarter results, in which Accelrys reported a 66 percent increase in revenues year over year. At that time, he said that in connection with the integration of the Symyx acquisition, "we are commencing the restructuring and streamlining of our content product lines in order to better integrate them with our software business."

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.